Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -54.67% is 44% below its 5-year average of -37.94%, near the low end of its 5-year range (-54.67%–-13.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.23% below its 12-month average of -50.05%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.67%.
RETURN ON EQUITY (ROE)
-54.67%
RETURN ON EQUITY (ROE) AVG TTM
-50.05%
RETURN ON EQUITY (ROE) AVG 3Y
-43.33%
RETURN ON EQUITY (ROE) AVG 5Y
-37.94%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.23%
CURRENT VS 3Y AVG
-26.17%
CURRENT VS 5Y AVG
-44.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.76%
median of 687 covered companies
CURRENT VS SECTOR MEDIAN
-34.13%
vs the sector median at left
Quantum-Si incorporated
Market Cap
$246.31M
Return on Equity (ROE)
-54.67%
TTM Avg
-50.05%
3Y Avg
-43.33%
5Y Avg
-37.94%
Market Cap
$244.06M
Return on Equity (ROE)
31.90%
TTM Avg
-385.06%
3Y Avg
-191.20%
5Y Avg
-142.10%
Market Cap
$243.66M
Return on Equity (ROE)
-695.56%
TTM Avg
-3698.55%
3Y Avg
-1897.26%
5Y Avg
-1268.80%
Market Cap
$242.50M
Return on Equity (ROE)
N/A
TTM Avg
-1340.59%
3Y Avg
-55.32%
5Y Avg
-61.68%
Market Cap
$249.88M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$241.78M
Return on Equity (ROE)
-43.11%
TTM Avg
-35.75%
3Y Avg
-28.47%
5Y Avg
-12.53%
Market Cap
$251.29M
Return on Equity (ROE)
-33.97%
TTM Avg
-31.77%
3Y Avg
-42.34%
5Y Avg
-36.86%
Market Cap
$236.60M
Return on Equity (ROE)
-59.27%
TTM Avg
-136.66%
3Y Avg
-113.26%
5Y Avg
-53.68%
Market Cap
$240.38M
Return on Equity (ROE)
N/A
TTM Avg
35.05%
3Y Avg
64.68%
5Y Avg
-167.54%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $246.31M | -54.67% | -50.05% | -43.33% | -37.94% |
| Q32 Bio Inc. (QTTB)vs › | $244.06M | 31.90% | -385.06% | -191.20% | -142.10% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | -695.56% | -3698.55% | -1897.26% | -1268.80% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | N/A | -1340.59% | -55.32% | -61.68% |
| Century Therapeutics, Inc. (IPSC)vs › | $249.88M | -47.25% | -42.23% | -50.43% | -29.25% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $241.78M | -43.11% | -35.75% | -28.47% | -12.53% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $251.29M | -33.97% | -31.77% | -42.34% | -36.86% |
| Invivyd, Inc. (IVVD)vs › | $236.60M | -59.27% | -136.66% | -113.26% | -53.68% |
| Galectin Therapeutics Inc. (GALT)vs › | $240.38M | N/A | 35.05% | 64.68% | -167.54% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | N/A | -125.28% | -42.20% | -43.41% |
ROE
-54.7%
ROA
-50.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -54.67% |
| 2026-03-31 | -51.72% |
| 2025-12-31 | -46.02% |
| 2025-09-30 | -49.69% |
| 2025-06-30 | -48.18% |
| 2025-03-31 | -40.79% |
| 2024-12-31 | -46.89% |
| 2024-09-30 | -42.72% |
| 2024-06-30 | -38.30% |
| 2024-03-31 | -36.18% |
| 2023-12-31 | -35.33% |
| 2023-09-30 | -36.65% |
| 2023-06-30 | -36.17% |
| 2023-03-31 | -35.66% |
| 2022-12-31 | -36.92% |
| 2022-09-30 | -33.22% |
| 2022-06-30 | -27.84% |
| 2022-03-31 | -26.79% |
| 2021-12-31 | -19.91% |
| 2021-09-30 | -15.21% |
| 2021-06-30 | -13.01% |
| 2021-03-31 | -147.81% |
| 2020-12-31 | -101.45% |
